The Life Sciences Center of Vilnius University (www.gmc.vu.lt/en/) is a partner institution of the European Molecular Biology Laboratory (www.embl.org) for genome editing technologies, established in September 2020, with the aim of advancing scientific understanding of the biology and mechanisms of CRISPR and other antiviral defense systems. The partnership is based on the scientific and technological potential of the VU LSC for targeted genome modification. Prof. Virginijus Šikšnys of VU LSC is one of the pioneers of the breakthrough CRISPR gene-editing technology, who did much of the early work characterizing the molecular machinery underlying CRISPR-Cas function.
We are an institution of world-class research and study, with outstanding people, a very collegial working environment, and excellent, up-to-date infrastructure.
The Life Sciences Center (VU LSC) is a faculty-level operational unit of Vilnius University (VU), a significant public research and higher education institution in Lithuania. VU LSC conducts scientific research, studies, and technological development in disciplines including biochemistry, molecular biology, genetics, neurobiology, molecular medicine, biotechnology, cell and structural biology, and other related sciences. The Center is home to 250 PhD degree researchers and around 1,000 undergraduate and postgraduate students. The integration of studies and research provides an ongoing stream of young talent.